Vr Adviser, LLC Viridian Therapeutics, Inc.\De Transaction History
Vr Adviser, LLC
- $414 Million
- Q1 2025
A detailed history of Vr Adviser, LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Vr Adviser, LLC holds 3,882,709 shares of VRDN stock, worth $65.2 Million. This represents 12.64% of its overall portfolio holdings.
Number of Shares
3,882,709
Previous 3,882,709
-0.0%
Holding current value
$65.2 Million
Previous $74.4 Million
29.68%
% of portfolio
12.64%
Previous 12.28%
Shares
11 transactions
Others Institutions Holding VRDN
# of Institutions
188Shares Held
79.7MCall Options Held
92.2KPut Options Held
55.2K-
Deep Track Capital, LP Greenwich, CT5.38MShares$90.3 Million2.54% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$80.1 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ4.7MShares$78.9 Million5.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.56MShares$76.6 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.6MShares$60.4 Million4.75% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $670M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...